Fortimedix Surgical news

Participation SAGES 2015

The 1-year follow-up data of the First-In-Man study and the results of the Phase II clinical study were accepted as part of the Emerging Technology Session of SAGES 2015 and presented by Dr. Hans Fuchs under the leadership of Dr. Santiago Horgan, generating significant recognition for the FMX314 product platform. Both the Emerging Technology Session and the exhibition made our participation during this year’s SAGES meeting very successful.

Related:
Go to the News IndexDownload as PDF

By using our website you consent to all cookies in accordance with our Cookie Policy.